Increased skin viability.

98.9%

Reduction
In senescent cells from 61.29 to17.34%.

Reduction
In IL-8 and Hs-CRP, inflammatory markers.

36%
Reduction in Upper Respiratory Tract Infection (URTI) severity and sick days.

98.9%
Increased skin viability.

Reduction
In senescent cells from 61.29 to17.34%.

Reduction
In IL-8 and Hs-CRP, inflammatory markers.

36%
Reduction in Upper Respiratory Tract Infection (URTI) severity and sick days.

98.9%
Increased skin viability.

Reduction
In senescent cells from 61.29 to17.34%.